The bone remodeling around hip prostheses appears to vary a great deal with different fixation methods and stem designs ([@CIT0013], [@CIT0006], [@CIT0020], [@CIT0010]). Even with the same implant, researchers have reported a variety of bone mineral density (BMD) changes. In implant research, BMD results are most often given in percentage change relative to the first postoperative measurement. The postoperative measurement is used as a reference to avoid measuring the changes in BMD due to the operation ([@CIT0017]). During surgery, bone is removed and compacted due to rasping and insertion of the stem. The reference measurement is of importance because it influences all later results. [@CIT0001] presented 2-year dual-energy X-ray absorptiometry (DXA) results, with 23% bone loss in Gruen zone 7 for the ABG-1 stem. [@CIT0023] reported 2 patient groups with 12% and 15% reduction in BMD in zone 7 for the same femoral stem. The only obvious difference in these 2 studies was the timing of the first measurement. Van der Wal performed the baseline measurement at 10 days postoperatively while Aamodt performed the first postoperative measurement 3--5 days after the operation. Rapid bone loss from day 3--5 to day 10 could therefore have explained the difference in bone loss at 2 years.

It is not fully known whether the bone loss starts immediately after the operation or after a few weeks. In the early postoperative period, BMD might change because of disuse atrophy ([@CIT0019]) or because of the trauma to the bone ([@CIT0012]). We hypothesized there is a rapid bone loss in the first days after operation, which would be an important source of bias to postoperative reference measurements.

Patients and methods {#ss2}
====================

We included 23 patients (15 women) who were operated with an uncemented HA-coated Corail stem (DePuy International Ltd., Leeds, UK). The inclusion criterion was indication for THA with an uncemented stem. Exclusion criteria were infection, revision arthroplasty, marked bone loss, medication with bone-active drugs, or severe morbidity. Mean age at time of operation was 64 (34--82) years. Recruitment was through informed consent. The Norwegian Data Inspectorate and the regional ethics committee approved the study, and it was carried out according to the Helsinki declaration.

BMD was measured with DXA by experienced technicians. 2 different DXA machines were used in 2 different institutions (Prodigy; Lunar, Madison, WI and Hologic QDR; Hologic Inc., Bedford, MA). Each patient was measured on the same machine on all occasions. The patients were placed supine on the scan table with a foot support to achieve a standard rotation of the hip. Orthopaedic software (Lunar version 1.2 and Hologic QDR version 12.3) was used to analyze periprosthetic BMD in 7 regions of interest (ROIs). The ROIs were based on the Gruen zones. The patients were measured 1--2 days postoperatively, and on days 5 and 14. For follow-up, they were measured after 3 months and 1 year. 16 patients underwent all 5 measurements.

Statistics {#ss3}
----------

The results were calculated as change in percent. Differences were compared by Wilcoxon signed rank test (non-parametric) using PASW statistics software version 18.0 (SPSS). To calculate precision error, all examinations were repeated on the same day with repositioning between the scans. The differences between these paired BMD measurements were used to calculate the coefficient of variation (CV) for each ROI: CV% = 100 × \[(δ/√2)/μ\] for each ROI, where δ represents the standard deviation of the difference between the paired BMD measurements, and μ is the overall mean of all the BMD measurements for each individual ROI.

Results {#ss4}
=======

The precision (CV) of DXA measurements varied from 0.8% in Gruen zone 4 to 5.1% in zone 7. Mean CV was 1.8% ([Table 1](#T1){ref-type="table"}).

###### 

The coefficient of variation (CV%) of the BMD measurements in different Gruen zones and overall

              Zone 1   Zone 2   Zone 3   Zone 4   Zone 5   Zone 6   Zone 7   Overall
  ----------- -------- -------- -------- -------- -------- -------- -------- ---------
  1 day       1.5      3.0      3.4      0.8      2.2      0.9      1.0      2.1
  5 days      1.2      2.9      1.9      1.1      2.6      1.7      2.0      2.4
  14 days     0.9      1.7      1.3      0.7      0.7      0.9      1.8      1.7
  3 months    1.2      1.0      1.1      1.0      1.0      1.1      1.0      1.4
  12 months   2.1      1.8      1.9      3.1      3.0      2.7      5.1      2.0

There was no change in BMD in the first 2 weeks postoperatively ([Figure 1](#F1){ref-type="fig"}). Between 14 days and 3 months, there was a mean bone loss of 8%, ranging from 18% in zone 7 to 4% in zones 4 and 5 (p \< 0.05 for all zones). There was restoration of bone in all zones from the 3-month to the 12-month follow-up ([Figure 2](#F2){ref-type="fig"}). This restoration was from 2% to 8% and was statistically significant in zones 2--6 (p = 0.02, p \< 0.001, p \< 0.001, p = 0.001, and p = 0.05). The BMD decreased most in zone 7: by 18% after 3 months ([Table 2](#T2){ref-type="table"}).

![Changes in bone mineral density (BMD) in different regions over the first 14 days after insertion of an uncemented femoral stem. Results are medians, given as percentages of the first postoperative value.](ORT-0300-9734-082-321_g001){#F1}

![Changes in bone mineral density (BMD) in different regions during the first year after insertion of an uncemented femoral stem. Results are medians, given as percentages of the first postoperative value.](ORT-0300-9734-082-321_g002){#F2}

###### 

Median bone mineral density in different regions after insertion of an uncemented femoral stem. Results are percent (range) after 5 days, 14 days, 3 months, and 12 months

              Zone 1          Zone 2         Zone 3         Zone 4          Zone 5          Zone 6          Zone 7          Global
  ----------- --------------- -------------- -------------- --------------- --------------- --------------- --------------- --------------
  5 days      101 (95--110)   98 (92--101)   99 (89--122)   101 (98--107)   101 (91--108)   100 (91--117)   99 (89--113)    99 (95--120)
  14 days     103 (96--107)   98 (90--106)   98 (90--125)   101 (96--112)   100 (91--107)   101 (92--109)   100 (91--109)   98 (90--111)
  3 months    89 (77--109)    89 (74--103)   93 (80--137)   97 (94--107)    96 (82--104)    92 (79--120)    82 (70--101)    94 (88--110)
  12 months   91 (73--102)    94 (84--111)   97 (90--139)   101 (95--114)   104 (93--127)   97 (82--114)    88 (66--100)    98 (91--114)

Discussion {#ss5}
==========

We found similar BMD values during the first 14 days after implantation of an uncemented femoral stem. Baseline measurement for bone remodeling studies with DXA can therefore be done at any time in this interval.

Bone changes around implants have been an area of continued interest. Aseptic loosening is thought to be the consequence of bone loss (often attributed to stress shielding) and an inflammatory process induced by foreign body particles ([@CIT0004], [@CIT0024], [@CIT0011]). The most informative and frequently used way to present periprosthetic bone remodeling is relative change as a function of time. Since there are different forms of bias related to use of preoperative measurements, such as disuse atrophy, sclerotic bone and peroperative bone loss, the recommended baseline is the first postoperative measurement ([@CIT0025]). [@CIT0023] stated that studies comparing BMD after operation with THA should be matched for preoperative BMD and sex. A correlation between preoperative BMD and postoperative bone loss indicates that the lower the BMD before operation, the higher is the bone loss after the operation ([@CIT0026], [@CIT0020], [@CIT0002]). [@CIT0013] defined 4 ROIs in the proximal femur of the operated hip and did not find any correlation between preoperative BMD and the postoperative bone-remodeling pattern. Their first postoperative measurement, done less than 5 days after the operation, showed an increased BMD in all 4 ROIs. All values almost returned to baseline within 1 month.

The most marked postoperative bone loss takes place in the first months after the operation. Bone loss of up to 21% has been reported in the first 3 months in Gruen zones 1 and 7 ([@CIT0005]). As in our study, [@CIT0022] also found an increase in BMD in the greater trochanter early after the operation. They took the first postoperative measurements at 2 months and compared these values with preoperative values. BMD appears to stabilize after approximately 6 months ([@CIT0018]). The main reason for bone loss is thought to be partial weight bearing and stress shielding. [@CIT0005] compared BMD in 20 patients randomized to partial or full weight bearing. The group with partial weight bearing had lost more bone in Gruen zones 1, 4, and 5 after 3 months than those with full weight bearing. Differences in BMD between study groups appear to level off with time. In the material of Boden and Adolphson, the difference due to weight bearing only remained for 2 years in zone 1. [@CIT0021] compared a polymethyl methacrylate-coated (PMMA-coated) stem, a polished stem, and a matte stem. Initially, the polished stem lost less bone and subsided more then the other two. After 5 years of follow--up, there was no difference. In our own study on Taperloc stems ([@CIT0007]), there was a significant difference in bone remodeling in the major trochanter between 2 different hydroxyapatite-coated stems during the first 2 years.

In addition to having reliable reference measurement, longitudinal studies depend on reproducibility. Rotation of the femur appears to be the most significant factor affecting reproducibility ([@CIT0008]). Repositioning of the patient between 2 measurements on the same day should give us reliable feedback on the precision of DXA measurements. In our study, a coefficient of variation below 5% indicated good precision, and daily scanning of a phantom allowed us to check for drift of the DXA machines.

Another factor influencing BMD around implants is operation technique. Compaction is a bone-saving technique compared to conventional bone-removing techniques by a rasp with similar shape as the stem. Using a dog model, [@CIT0015] showed that operation with compaction around an HA-coated implant increased the peri-implant bone density and bone implant contact. This indicates that compaction may be an advancement in human joint replacement to enhance initial fixation. Even though compaction represents autograft of non-vital bone, which is resorbed over time, the fixation does not appear to be inferior after bone resorption ([@CIT0016]). To our knowledge, the technique has not been tested in a human clinical trial. Perhaps compaction is the reason for increased BMD immediately after surgery, since most of the rasps that are used can probably both compact and remove bone. It is of some concern that the risk of femoral fractures increases with compaction ([@CIT0014]).

Bone remodeling after implantation of prostheses may be compared to remodeling after partial weight bearing because of fractures. [@CIT0009] found a definite and persistent loss of BMD in the distal tibia 5--11 years after fracture. At the fracture site, there was sclerosis and a higher BMD than on the control side. In that material, there was no improvement in BMD with weight bearing. Fractures sustained in childhood did not lead to bone loss in the distal tibia. There have been several publications indicating that bone loss may be the result of a fracture, and not necessary the cause of it ([@CIT0003], [@CIT0009], [@CIT0012]). [@CIT0012] published BMD results from both legs, both hips, spine, and total body in patients who were operated with tibial osteotomy for localized medial osteoarthritis. They found substantial bone loss in the whole body, the spine, and the contralateral hip after 9 and 15 months. In the leg with osteotomy, the bone loss was significant in the distal femur after 4 months (compared to baseline) and in the shaft of the tibia after 9 and 15 months. The conclusion from that work was that bone loss following an osteotomy is rapid, affects both fractured and unfractured bones, and is not completely reversible. The same mechanisms may be responsible for the bone remodeling seen after implantation of prostheses, but the exact reason for this "post-traumatic" bone loss is unknown.
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